Program by day

10:00 – 10:00 – 18:00 Registration
HALL BILJANA (HALL 1)
18:00 – 19:30 Opening ceremony

Welcome address
President of Organizing Committee – Rumenka Petkovska
Dean of Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje – Zoran Sterjev
President of Scientific Committee – Marija Glavas Dodov

Opening lecture: Drug discovery and bioexploration of nature: toxins, friend or foe?
Jan Tytgat, Faculty of Pharmaceutical Sciences, Catholic University of Leuven, Belgium

HALL BELLEVUE

20:00-22:00 Welcome cocktail

HALL BILJANA (HALL 1)
9:00 – 12:00 PLENARY SESSION

Chair persons: Svetlana Kulevanova, Ales Mrhar
9:00-9:30 Family pharmacist: a Belgian view on the future role of the pharmacist – Hendrik De Rocker, Pharmacist – Secretary General (Dutch), APB, Brussels, Belgium
9:30 – 10:00 Searching for bioactive compounds against SARS-CoV-2 from traditional Chinese medicines Yang Ye, Deputy Director of Shanghai Institute of Materia Medica, Shanghai, PR China
10:00 – 10:30 Mini-tablets for drug delivery in individual therapy – Janina Lulek, Chair of Department of Pharmaceutical Technology, Poznan University of Medical Sciences, Poland
10:30-11:00 COFFEE BREAK
11:00-11:30 Targeting cell fitness competition to induce beta-cell regeneration in diabetes – on the route from scientific to drug discovery Slavica Tudzarova, Endocrinology/Medicine and Jonsson Comprehensive Cancer Center, University of California Los Angeles
11:30-12:00 Bacteriophage therapy for infectious diseases Hari Polenakovik, MD FACP FIDSA, Professor of Medicine, Boonshoft School of Medicine – Wright State University; Co-Director, Adult Cystic Fibrosis Program, Wright State University and Dayton Children’s; Chief, Infectious Diseases Section, Dayton VAMC, USA

12:30-14:00 ALKALOID AD, Skopje, Professional Symposium (sponsored)
14:30-15:00 SALVEO dooel, Skopje, Professional Symposium (sponsored)

15:30 – 18:30 Session: PHARMACOECONOMY/DRUG INFORMATION

Chair persons: Ljubica Suturkova, Zoran Sterjev
15:30-15:50 The increasing role of health economics in the HTA of COVID19-vaccines  – Maarten Postma
15:50-16:10 The National Medicines Policy 2018-22 in Poland. From creation to implementation – Marcin Czech
16:10-16:30 Pharmacoeconimics an safety; What is the economic and health impact of reducing inappropriate inhaled corticosteroids use in patients with chronic obstructive pulmonary disease? – Tanja Fens
16:30-16:50 Meeting the affordability challenges in the access of drugs for rare disease in the RN Macedonia – Aleksandra Kapedanovska Nestorovska
16:50-17:10 COFFEE BREAK
17:10-17:25 Changes in the R&D process and consequences on drug pricing – Rubin Zareski
17:25-17:40 Management of national pricing policy of medicines – Kristina Hristov
17:40-17:55 Comparison of Parallel Trade in North Macedonia and Parallel Import in EU – Bojana Danilovska Brashnarska
17:55-18:10 Monitoring and reporting of off-label use of drugs through pharmacovigilance system – Jehona Aliju Shakiri, Zorica Naumovska
18:10-18:30 Discussion

HALL CAR SALOIL (HALL 2)
15:30 – 18:30 Session: CARREER OPPORTUNITIES / STUDENTS’ ORAL PRESENTATIONS

Chair person: Jasmina Tonic Ribarska
15:30-15:50 Alkaloid’s young talents program – Tane Murgoski
15:50-16:00 Regulatory procedures – Semra Bejtovic
16:00-16:10 Development of new generic drug formulation and process – Biljana Temelkovska
16:10-16:20 Discussion

Chair persons: Natalija Nakov, Nikola Geskovski
16:20-16:30 Pharmacy students’ experience during the Covid-19 pandemic and its impact on their health, academic endeavors and overall perceptions-a study – Metodi Naumoski
16:30-16:40 Evaluation of antioxidant properties of Hypericum perforatum and Calendula officinalis extracts as well as CBD oil for the treatment of chronic wound – Anastazija Cenova
16:40-16:50 Formulation and characterization of snail slime-chitosan microparticles with herbal extracts intended for treatment of chronic wounds – Martina Nestorovska
16:50-17:10 COFFEE BREAK
17:10-17:20 Image analysis of surface colour of film-coated tablets – Iskra Velevska
17:20-17:30 Drug abuse and misuse: Core knowledge, attitudes and opinions of pharmacy students and community pharmacists in Republic of North Macedonia – Meni Stevanovska
17:30-17:40 Correlation of Vitamin D and Zinc concentration with therapy outcome in epilepsy patients from Republic of North Macedonia – Damjan Georgievski
17:40-17:50 Resource assessment of bilberries on Kozuf Mtn., R.N. Macedonia – Filip Todorov
17:50-18:00 COVID-19 vaccine acceptance among university students in Republic of North Macedonia – Mateja Stojceva
18:00-18:10 Stereomicroscopy as a potent analytical method for detection of glass micro-particles generated during snap-opening of ampoules – Margarita Taneva
18:10-18:20 Evaluation of patient-centered counselling in Macedonian community pharmacies – Magdalena Radovikj
18:20-18:30 Individual variability of the cannabinoids’ content in outdoor cultivated Bubba Kush x OG Kush Cannabis strain – Andrea Belazelkoska

BUSINESS HALL  (HOTEL METROPOL)

12:30-14:30 Poster sessions/Exhibition

HALL BILJANA (HALL 1)
9:00 – 12:00 Session: PHARMACEUTICAL CHEMISTRY/BIOMOLECULAR SCIENCES AND CLINICAL PHARMACY

Chair persons: Ljubica Suturkova, Aleksandar Dimovski
9:00-9:20 Clinical Pharmacist – Psychopharmaca: from Pharmacokinetics to Clinical Outcomes – Ales Mrhar
9:20-9:40 Next generation therapeutic biodrugs – Slavica Tudzarova
9:40-10:00 Pharmacological applications of modulators of oxidative stress – Luciano Saso
10:00-10:20 Acylcarnitines in health and disease: biomarkers and drug targets – Maija Dambrova
10:20-10:40 COFFEE BREAK
10:40-11:00 Short synthetic oligonucleotides as therapeutic or diagnostic tools – Marija Taskova
11:00-11:10 COVID-19 vaccination in rituximab-treated patients with rheumatic disorders – Evgenija Mihajloska
11:10-11:20 Concomitant influence of CYP2D6 phenotype and ABCB1 overall haplotype/genotype on pharmacokinetics of risperidone and 9-hydroxyrisperidone in healthy volunteers – Aleksandar Dimkovski
11:20-11:30 Targeting the oxidative stress in neurodegenerative disorders with multifunctional benzimidazole and indole hybrids – Neda Anastassova
11:30-11:40 Antioxidant properties of a novel triazole ligand – Lozan Todorov
11:40-11:50 A new series of chalcones endowed with potent anticancer activity towards A549 cells – Ahmet Özdemir
11:50-12:00 Discussion

12:30-13:30 PLIVA-TEVA dooel, Skopje, Professional Symposium (sponsored)
14:00-15:00 KRKA-FARMA dooel, Skopje, Professional Symposium (sponsored)
15:30-16:30 Novo Nordisk Farma dooel, Skopje, Professional Symposium (sponsored)
17:00-17:30 Galenika dooel, Skopje, Professional Symposium (sponsored)
17:40-18:10 LEK SKOPJE, dooel, Professional Symposium (sponsored)

HALL CAR SAMOIL (HALL 2)
9:00 – 12:00 Session: PHARMACEUTICAL TECHNOLOGY AND BIOTECHNOLOGY/BIOPHARMACY AND COSMETOLOGY

Chair persons: Katerina Goracinova, Maja Simonoska Crcarevska, Rok Dreu, Nikola Geskovski
9:00-9:25 Nanotechnology in medicine – our experiences – Katerina Goracinova
9:25-9:50 Accurate and controlled coating of particles and tablets – Rok Dreu
9:50-10:15 Orally Disintegrating Tablets (ODTs): An innovative approach to tablet formulations – Tansel Comoglu
10:20-10:40 COFFEE BREAK
10:40-10:55 Lipid nano-carriers with herbal extracts for targeted brain delivery and treatment of CNS disorders – Dushko Shalabalija
10:55-11:10 Insight into the efficacy of lipid nano-systems for brain delivery – uptake and internalization pathways in different cell culture lines – Ljubica Mihailova
11:10-11:25 Improvement of content uniformity in low-dose powder blends: critical formulation and process variables – Liljana Makraduli
11:25-11:40 Applicability of Expert system for drug development as a tool for co-processed excipients formulation development – Ivana Vasiljevic
11:40-12:00 Discussion

HALL OHRID (HALL 3)
9:00 – 12:00 Session: SOCIAL PHARMACY/PHARMACEUTICAL LAW

Chair persons: Aleksandra Grozdanova, Katerina Ancevska Netkovska
9:00-9:30 The travails of health policy making: from planning to implementation – Husein Reka
9:30-10:00 The role of the pharmacist in patient-centered medicine practices: current perspectives – Jelena Micik
10:00-10:20 Impact of the SARS-CoV-2 pandemic on routine immunization of the population in the Republic of North Macedonia – Zana Mustafa
10:20-10:40 COFFEE BREAK
10:40-11:00 “Skinny labelling” pathway: an instrument for circumventing second medical use patents by generic companies – Marija Mitkovska
11:00-11:20 Self-reported anxiety levels in a cluster of Albanian University students: a comparative study – Suela Kellici
11:20-11:40 Intellectual property rights and advertising of cosmetic products in Republic of North Macedonia – Biljana Nestorovska
11:40-12:00 Discussion

BUSINESS HALL (HOTEL METROPOL)

12:30-14:30 Poster sessions/Exhibition

HALL BILJANA (HALL 1)
9:00 – 12:00 Session: COMMUNITY PHARMACY/HOSPITAL PHARMACY

Chair persons: Aleksandra Kapedanovska Nestorovska, Maja Simonoska Crcarevska
9:00-9:20 Polish community pharmacies – new solutions and changes step by step – Mikołaj Konstanty
9:20-9:40 Hospital Pharmacists’ Preparedness in Times of Crisis – Nenad Miljkovic
9:40-10:00 The role of hospital pharmacists during Covid-19 pandemic in the Republic of North Macedonia – Zorica Naumovska
10:00-10:20 How to integrate the Pharmacy Game in your Pharmacy Curriculum? – Tanja Fens
10:20-10:40 COFFEE BREAK
10:40-10:50 Building a draft national strategy for implementation of pharmaceutical care in patients with chronic diseases in Republic of North Macedonia – Donka Pankov
10:50-11:00 Regulatory aspects of introducing new health services in the community pharmacies in RN Macedonia – Jasminka Patcheva
11:00-11:10 The ethical dilemmas in community pharmacy practice: quantitative study in Macedonia – Kiril Georgiev
11:10-11:20 Pharmaceutical care in COPD patients: experience and expectations – Biljana Bozhinovska
11:20-12:00 Discussion

12:30-13:30 EUROFARM dooel, Bitola, Professional Symposium (sponsored)
14:00-15:00 REPLEK AD, Skopje, Professional Symposium (sponsored)
15:30-16:30 SEPTIMA dooel, Skopje, Professional Symposium (sponsored)

HALL CAR SAMOIL (HALL 2)
9:00 – 12:00 Session: PHARMACEUTICAL ANALYSIS/QUALITY ASSURANCE/REGULATORY AFFAIRS

Chair persons: Aneta Dimitrovska, Suzana Trajkovikj Jolevska
9:00-9:20 Cannabis for Medicinal purposes – Quality control criteria and methods – Luis Meirinhos-Soares
9:20-9:40 Contribution of Raman chemical imaging for the analysis of falsified and substandard medical products – Hervé Rebiere
9:40-9:55 The GEONs API-fingerprint program: tackling falsifications of APIs – Eric Deconinck
9:55-10:10 Static and dynamic quantum mechanical methods for exact interpretation of infrared multiple photon dissociation spectra: current state and development perspectives – Blagoj Achevski
10:10-10:20 Discussion
10:20-10:40 COFFEE BREAK
10:40-10:55 A regulatory perspective: Examples from microbiological quality control of non-sterile medicinal products – Sanja Milovanovic
10:55-11:10 Determination of nitrosamines in different pharmaceutical forms – John Upton
11:10-11:25 Possibilities and challenges of “green” chromatographic solutions – Natalija Nakov
11:25-11:40 Scientific approach and implementation of a measurement uncertainty in mass balance determination – Maja Hadzieva Gigovska
11:40-12:00 Discussion

HALL OHRID (HALL 3)
9:00 – 12:00 Session: CLINICAL BIOCHEMISTRY/TOXICOLOGY/FOOD AND NUTRITION

Chair persons: Tatjana Kadifkova Panovska, Marija Hiljadnikova Bajro, Tanja Petreska Ivanovska
9:00-9:20 The Medical Biochemistry and Laboratory Medicine are important dignostic branches – Snezana Jovicic
9:20-9:40 Better understanding of dietary fats – a path to better health – Sladjana Sobajic
9:40-9:55 Relevance of dietary and lifestyle patterns in metabolic syndrome management – Tanja Petreska Ivanovska
9:55-10:10 Toxicity assessment of weight loss supplements and possible interaction risk with lipid-lowering and antihypertensive drugs in HepG2 cell line – Zoran Zivic
10:20-10:40 COFFEE BREAK
10:40-10:55 The importance of AKR1D1 enzyme in drug metabolism – Kristina Shutevska
10:55-11:10 Influence of the nitrification stage of biological treatment to the levels of nitrogen compounds in wastewater treatment – Aleksandra Mitevska
11:10-11:25 Alcohol involvement in fatal traffic accidents – Marija Bujaroska
11:25-11:40 Genetic alterations landscape of lung cancer patients and their therapeutic value: an overview – Milka Ljonceva
11:40-12:00 Discussion

BUSINESS HALL  (HOTEL Metropol)

12:30-14:30 Poster sessions/Exhibition

18:00 – 19:00 HOTEL GRANIT
CLOSING REWARDS AND BEST STUDENT’S ORAL/POSTER PRESENTATION AWARD CEREMONY